IMPEL NEUROPHARMA
Impel NeuroPharma is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory Delivery (POD) system with well-established therapeutics, including TRUDHESA™ for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease.
IMPEL NEUROPHARMA
Industry:
Biotechnology Delivery Health Care Medical Device
Founded:
2008-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.impelnp.com
Total Employee:
11+
Status:
Active
Contact:
2067261217
Total Funding:
261.31 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA GoDaddy DNS Person Schema Cloudflare Hosting COVID-19 Gravatar Profiles
Similar Organizations
Accuray
Accuray is a biomedical company that provides medical practices with tumor treatment solutions.
Aerin Medical
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Apollo Endosurgery
Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases.
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Endomaster
EndoMaster is a medical device company that is developing a novel robotic-assisted surgical system.
Flow Neuroscience
Flow Neuroscience is a healthcare company that develops direct current stimulation device and behavioral therapy app for depression.
ClearPoint Neuro
ClearPoint Neuro is a platform neuro company that enables therapy for neuro disorders with pinpoint accuracy.
NuVasive
NuVasive is a medical device company developing minimally disruptive surgical products and procedurally integrated solutions for the spine.
RxSight
RxSight is a medical device company that offers an intraocular lens and cataract surgery solutions.
SceneRay
SceneRay is a medical device company dedicated to the design, Development, and distribution of neuromodulation devices.
Sigma Genetics, Inc
Sigma Genetics is building a non-invasive device that can deliver charged molecules, such as DNA, RNA, and proteins into patient cells
Spectral AI
Spectral AI specializes in predictive analytics with a platform that uses proprietary artificial intelligence (AI).
Vapotherm
Vapotherm is a medical device company that develops a mask-free respiratory support tool.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oaktree Capital Management
Oaktree Capital Management investment in Post-IPO Debt - Impel NeuroPharma
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Impel NeuroPharma
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Impel NeuroPharma
Vivo Capital
Vivo Capital investment in Series D - Impel NeuroPharma
Norwest Venture Partners
Norwest Venture Partners investment in Series D - Impel NeuroPharma
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Series D - Impel NeuroPharma
venBio Partners
venBio Partners investment in Series D - Impel NeuroPharma
5AM Ventures
5AM Ventures investment in Series D - Impel NeuroPharma
5AM Ventures
5AM Ventures investment in Series C - Impel NeuroPharma
Vivo Capital
Vivo Capital investment in Series C - Impel NeuroPharma
Official Site Inspections
http://www.impelnp.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Impel NeuroPharma"
IMPEL NEUROPHARMA ANNOUNCES KEY MANAGEMENT TEAM …
Mar 1, 2021 Leonard S. Paolillo Appointed as Chief Commercial Officer, Gerald F. Penn Appointed as Vice President, Market Access & Trade Significant Leadership Experience …See details»
Home | Impel Pharmaceuticals
Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet medical needs through the pioneering of an optimized …See details»
Impel NeuroPharma Announces Key Management Team …
SEATTLE, March 1, 2021 /PRNewswire/ -- Impel NeuroPharma, a late-stage pharmaceutical company focused on utilizing our proprietary technology to develop and commercialize …See details»
Impel Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected]. Phone Number 2067261217. Impel Pharmaceuticals is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop …See details»
Impel Pharmaceuticals CEO and Key Executive Team | Craft.co
Impel Pharmaceuticals's Chief Technology & Development Officer is John Hoekman. Other executives include Michael W. Kalb, Chief Financial Officer; Leonard S. Paolillo, Chief …See details»
Impel Pharmaceuticals | LinkedIn
Impel Pharmaceuticals Pharmaceutical Manufacturing Seattle, Washington 9,556 followers Developing life-changing, innovative therapies for diseases with unmet needsSee details»
About Impel - Impel Pharmaceuticals
Impel Pharmaceuticals’ mission is to create and provide transformative therapies for people suffering from diseases with high unmet medical needs. We have pioneered an approach to …See details»
Impel NeuroPharma Announces Appointment Of Adrian Adams As …
Jan 9, 2020 Impel has developed dry powder and liquid compatible POD devices to improve upon current treatment options for central nervous system (CNS) disorders. Contact: Melyssa …See details»
Impel NeuroPharma Announces Appointment Of Diane Wilfong …
Oct 17, 2019 Impel has developed dry powder and liquid compatible POD devices to improve upon current treatment options for central nervous system (CNS) disorders. Contact: Melyssa …See details»
Impel Neuropharma Announces Company Will Now Be Known as …
Apr 25, 2022 Impel Celebrates Its One-Year Anniversary as a Public Company Today at the Nasdaq Stock Market Closing Bell Ceremony Starting at 3:45 p.m. EDTSEATTLE, April 25, …See details»
Impel NeuroPharma Announces Key Management Team …
Mar 1, 2021 "I am delighted to welcome these industry professionals to our team at this exciting time in Impel NeuroPharma's evolution into a commercial-stage organization," said Adrian …See details»
Impel NeuroPharma Board Announces Appointment of Jon …
Oct 3, 2017 Contact: Sutapa Ray, PhD 206-568-1466 [email protected]. CONNECT WITH US. link to Twitter . link to linkedIn. Impel Pharmaceuticals is a commercial-stage pharmaceutical …See details»
Impel NeuroPharma To Present At The 21st Annual Needham
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative...See details»
Organization: Impel NeuroPharma LEI 549300OM070Y5YFLMR84
Impel NeuroPharma. Information about the issuer. News and credit ratings. (LEI 549300OM070Y5YFLMR84). Tables with accounting and financial reporting.See details»
Impel NeuroPharma Partners with Veeva Systems to Build …
Feb 10, 2021 Impel adopting Veeva software, data, and consulting to accelerate pre-launch planning and digital-first commercial execution. SEATTLE and PLEASANTON, CA – Feb. 10, …See details»
Chris Jeffries - Senior Director - Catalyst Pharmaceuticals, Inc ...
Welcome back. Senior Director, Financial Planning & Analysis at Impel NeuroPharma · Experience: Catalyst Pharmaceuticals, Inc. · Location: Whitehouse Station · 495 connections …See details»
IMPEL NEUROPHARMA APPOINTS JOHN LEAMAN AS CHIEF …
Impel NeuroPharma, Inc., is a privately-held, Seattle-based biopharmaceutical company devoted to creating life-changing, innovative therapies for central nervous system (CNS)See details»
Impel NeuroPharma Announces Pricing of $45.0 Million Public
Sep 10, 2021 Impel NeuroPharma Announces Pricing of $45.0 Million Public Offering. September 09, 2021 20:00 ET | Source: Impel NeuroPharma. Follow. SEATTLE, Sept. 09, …See details»
Join Impel - Impel Pharmaceuticals
Impel Pharmaceuticals is a commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high unmet medical needs.See details»
Impel NeuroPharma Announces Pricing of $80.0 Million
SEATTLE, April 22, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and …See details»